Husain Attarwala is a clinical pharmacologist, pharmacometrician and a researcher in drug development. Currently, he is serving as Head of Clinical Pharmacology and Pharmacometrics at Moderna. His research focus on developing predictive models to guide clinical dose decisions for mRNA vaccines and therapeutics. Previously, Husain was a Principal Scientist at Alnylam Pharmaceuticals where his research helped guide dose selection for various novel siRNA therapeutics, 5 of which have received global regulatory approvals. He has obtained PhD and MS degrees in Pharmaceutical Sciences and Drug Delivery Systems from Northeastern University, and a Bachelors in Pharmacy from Al-Ameen college of pharmacy.